Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,551 | 66,329 | 77,617 | 76,190 | 31,269 |
| Marketable Securities | 232,670 | 365,343 | 145,918 | 364,506 | 244,693 |
| Receivables | 41,123 | 31,057 | 27,625 | 26,198 | 19,928 |
| Inventories | 7,730 | 6,100 | 4,988 | 4,910 | 5,424 |
| Other current assets | 14,000 | 14,000 | 0 | 0 | 0 |
| TOTAL | $458,636 | $499,253 | $266,463 | $478,501 | $307,358 |
| Non-Current Assets | |||||
| PPE Net | 195 | 633 | 1,002 | 1,675 | 1,050 |
| Investments And Advances | 57,176 | 4,947 | 112,277 | 36,196 | 39,352 |
| Other Non-Current Assets | 105,510 | 78,597 | 44,014 | 55,359 | 64,552 |
| TOTAL | $162,881 | $84,177 | $157,293 | $93,230 | $104,954 |
| Total Assets | $621,517 | $583,430 | $423,756 | $571,731 | $412,312 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,396 | 11,976 | 6,908 | 10,554 | 7,537 |
| Accrued Expenses | 35,330 | 28,573 | 40,107 | 13,704 | 6,477 |
| TOTAL | $104,505 | $72,491 | $47,541 | $47,494 | $38,841 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 0 | 0 | 0 | 501 | 1,903 |
| TOTAL | $10,307 | $9,097 | $409 | $899 | $2,289 |
| Total Liabilities | $114,812 | $81,588 | $47,950 | $48,393 | $41,130 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,517 | 107,899 | 105,962 | 117,312 | 114,595 |
| Common Shares | 133 | 131 | 127 | 122 | 120 |
| Retained earnings | 402,526 | 296,386 | 194,968 | 82,456 | -23,555 |
| Other shareholders' equity | 531 | -1,017 | -638 | 620 | 557 |
| TOTAL | $506,705 | $501,842 | $375,806 | $523,338 | $371,182 |
| Total Liabilities And Equity | $621,517 | $583,430 | $423,756 | $571,731 | $412,312 |